Effects of short-term subcutaneous administration of SMS 201-995 on calcitonin plasma levels in patients suffering from medullary thyroid carcinoma

Horm Metab Res. 1989 Oct;21(10):584-6. doi: 10.1055/s-2007-1009294.
No abstract available

MeSH terms

  • Adolescent
  • Adult
  • Calcitonin / blood*
  • Carcinoma / blood
  • Carcinoma / drug therapy*
  • Drug Administration Schedule
  • Drug Evaluation
  • Female
  • Humans
  • Injections, Subcutaneous
  • Male
  • Middle Aged
  • Octreotide / administration & dosage
  • Octreotide / therapeutic use*
  • Thyroid Neoplasms / blood
  • Thyroid Neoplasms / drug therapy*

Substances

  • Calcitonin
  • Octreotide